CID news

New results from the global WILLOW phase 2 clinical trials published in The Lancet and Lancet Rheumatology indicate that enpatoranis highly effective for treating lupus patients with skin involvement.

To celebrate Clinical Trials Day 2026, we brought our clinical and legal teams together, offering the Monash Office of the General Counsel a unique opportunity to experience the 'real-time' science behind the contracts.

Congratulations to Dr Peter Eggenhuizen on being named a finalist for the Basic Science Researcher Award in the 2025–26 Victorian Premier’s Awards for Health and Medical Research.

Two School of Clinical Sciences at Monash Health researchers were recognised at the highest level at the 22nd International Vasculitis Workshop, a landmark global conference held in Melbourne.

Two researchers from the School of Clinical Sciences (SCS) at Monash Health have been awarded competitive Heart Foundation grants for 2025.

From advancing global lupus research to transforming paediatric care and redefining how professionalism is taught in dietetics, the School of Clinical Sciences at Monash Health continues to lead at the intersection of discovery, innovation and

Australia is a step closer to having its own national agency to inform and co-ordinate public health responses – a permanent Australian Centre for Disease Control (CDC).

A new study led by researchers at the Centre for Inflammatory Diseases has shown that the brain’s own immune cells, microglia, are the key culprits driving damaging inflammation within just three hours of stroke onset.

Congratulations to Professor Richard Kitching, who has been awarded the 2025 Asian Pacific Society of Nephrology Award for Excellence in Basic Science.